RAB37 and neoplasm: Our cell and animal models demonstrated that Rab37 act as an anti-cancer stemness protein through regulating Wnt antagonist, SFRP1, for exocytosis to inactivate Wnt signaling, leading to down-regulation of sphere formation and stemness genes expression and thus inhibiting xenograft tumor initiation growth (Fig. 5d).